Rheumatoid Arthritis Warrior’s Blog: Site Reactions, part 2
Thank you for the many inspiring comments and emails. These last two weeks have been like a whirlwind. One day, I decided I just couldn’t wait any longer. I still do not have all my ducks in a row, but here we are anyway.
Click on “comment” below a story. Write inside the comment box. Write as much as you like. Click “post comment.” I will reply as soon as I am able to do so.
Blogs use “members” to add credibility. It helps other readers know that people find this blog useful. You can either follow publicly or privately – and with or without a picture of you or your dog. ;D Just click on “join this blog” and you will be prompted.
This is just a way to make it easier for you to remember to read the blog every day. It’s like a newspaper subscription – only free. There are a few ways you can subscribe to Rheumatoid Arthritis Warrior: Just click on the big orange and red “Subscribe” link at the side of the page. You’ll open a window to subscribe via RSS (that’s Really Simple Syndication) or Email. Just click to see your options. You can choose a favorite reader or follow the Email option prompts. Then, a little permission window from your own computer will ask you to confirm / allow.
There are options at the end of each post which you can use to refer others to this post. These allow you to easily post this blog entry to Facebook, Twitter or Stumble, helping others to find the great content here. If you choose “email” you can email a link to Rheumatoid Arthritis Warrior to friends. That is just to help more people find this RA blog.
Finally, yes, I did my shots yesterday and the other kind of site reaction continues also. I appreciate your concern and prayers as I try to unsubscribe to my bee sting. ;D (After about 6 months on Enbrel, it was discontinued. You can read more about that on this blog post.)
NOTE: Your comments are an important resource for future readers of this post in the months to come. Please find the comment link below each post.Kelly Young. All rights reserved.